AR241159A2 - Substituted 2-oxindole-1-carboxamide intermediates - Google Patents

Substituted 2-oxindole-1-carboxamide intermediates

Info

Publication number
AR241159A2
AR241159A2 AR30025985A AR30025985A AR241159A2 AR 241159 A2 AR241159 A2 AR 241159A2 AR 30025985 A AR30025985 A AR 30025985A AR 30025985 A AR30025985 A AR 30025985A AR 241159 A2 AR241159 A2 AR 241159A2
Authority
AR
Argentina
Prior art keywords
formula
oxindole
substituted
carboxamide
alkyl
Prior art date
Application number
AR30025985A
Other languages
Spanish (es)
Other versions
AR241159A1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR241159A1 publication Critical patent/AR241159A1/en
Publication of AR241159A2 publication Critical patent/AR241159A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR UN COMPUESTO DE 2-OXINDOL-1-CARBOXAMIDA DE FORMULA (I), O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO; R ES H, HALOGENO O TRIFLUOROMETILO; R1 ES ENTRE OTRAS ALQUILO, TRIFLUOROMETILO, FENOXIMETILO; R2 ES ENTRE OTROS ALQUILO, CICLOHEXILO, BENCILO, FENILO, FLUOROFENILO; EL PROCESO SE BASA EN REACCIONAR UN COMPUESTO DE FORMULA (V) CON UN DERIVADO ACTIVADO DE UN ACIDO CARBOXILICO D FORMULA R1-C(O)-OH, EN UN SOLVENTE INERTE; TENIENDO X, R1 Y R2 LOS SIGNIFICADOS MENCIONADOS.A PROCEDURE FOR PREPARING A COMPOUND OF 2-OXINDOL-1-CARBOXAMIDE OF FORMULA (I), OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; R IS H, HALOGEN OR TRIFLUOROMETILE; R1 IS AMONG OTHER ALKYL, TRIFLUOROMETHYL, PHENOXYMETHYL; R2 IS AMONG OTHER ALKYL, CYCLOHEXYL, BENZYL, PHENYL, FLUOROPHENYL; THE PROCESS IS BASED ON REACTING A COMPOUND OF FORMULA (V) WITH AN ACTIVATED DERIVATIVE OF A CARBOXYLIC ACID D FORMULA R1-C (O) -OH, IN AN INERT SOLVENT; HAVING X, R1 AND R2 THE MENTIONED MEANINGS.

AR300259A 1984-05-04 1985-05-02 A PROCEDURE FOR PREPARING A COMPOUND OF 2-OXINDOL-1-CARBOXAMIDE AND COMPOUND OBTAINED AR241159A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
AR241159A1 AR241159A1 (en) 1991-12-30
AR241159A2 true AR241159A2 (en) 1991-12-30

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
AR300259A AR241159A1 (en) 1984-05-04 1985-05-02 A PROCEDURE FOR PREPARING A COMPOUND OF 2-OXINDOL-1-CARBOXAMIDE AND COMPOUND OBTAINED

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
FI851756A0 (en) 1985-05-03
BG60208B2 (en) 1993-12-30
AR241159A1 (en) 1991-12-30
RU2017729C1 (en) 1994-08-15
MW1685A1 (en) 1986-09-10
RO94455A (en) 1988-06-30
ES542813A0 (en) 1986-07-16
NO163132B (en) 1990-01-02
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
PT80375B (en) 1987-09-30
IN161509B (en) 1987-12-19
HUT37754A (en) 1986-02-28
RO91141A (en) 1987-06-30
PL145416B1 (en) 1988-09-30
PL253203A1 (en) 1986-06-17
RO94455B (en) 1988-07-01
FI80016C (en) 1990-04-10
MA20424A1 (en) 1985-12-31
ES8707182A1 (en) 1987-07-16
CS320285A2 (en) 1987-03-12
ES551275A0 (en) 1987-07-16
ZA853324B (en) 1986-12-30
HU196057B (en) 1988-09-28
YU44998B (en) 1991-06-30
PL257892A1 (en) 1986-10-07
BG60207B2 (en) 1993-12-30
DD232916A5 (en) 1986-02-12
IE851103L (en) 1985-11-04
KR850008154A (en) 1985-12-13
PT80375A (en) 1985-05-01
MX5839A (en) 1993-11-01
ZW7885A1 (en) 1985-07-24
ES8609248A1 (en) 1986-07-16
NO851774L (en) 1985-11-05
CS252828B2 (en) 1987-10-15
FI851756L (en) 1985-11-05
KR870000497B1 (en) 1987-03-12
JPS60243068A (en) 1985-12-03
FI80016B (en) 1989-12-29
YU73085A (en) 1988-04-30
NO163132C (en) 1990-04-11
RO91141B (en) 1987-07-03
EG17193A (en) 1990-08-30
OA08098A (en) 1987-03-31
SU1468413A3 (en) 1989-03-23

Similar Documents

Publication Publication Date Title
FI882819A (en) An analogous method for the preparation of a therapeutically active d-isomer of medetomidine
HUT59376A (en) Process for producing r(+)-n-propargyl-1-aminoindane and pharmaceutical compositions comprising such compound
DK381583D0 (en) METHYL-SUBSTITUTED 4-METOXYPYRIDINE-N-OXYDER
AR241528A1 (en) Alkylsulfonamidophenylalkylamines
DK306586A (en) PYRIDON CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
SE8600017D0 (en) NEW COMPOUND
AR241159A2 (en) Substituted 2-oxindole-1-carboxamide intermediates
GB1297386A (en)
PH25106A (en) 1-acyl-3-(4-(2-pyrimidinyl)-1-piperazinyl) propanes, pharmaceutical composition containing said compound and method of use thereof
GB1515060A (en) 3-hydroxymethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid esters
GB1320484A (en) 2,6-diaminobenzoic acid derivatives
EP0095451A3 (en) Novel dihydropyridines
SE8402361L (en) NEW ACYLAMINOPHENOLD DERIVATIVES
KR880001637A (en) Substituted isoquinoline derivatives, preparation method thereof, and anti-ulcer agent containing the same
GB1262333A (en) New hydantoins their preparation and compositions containing them
AU5758880A (en) Oxazoline and thiazoline derivatives
SE7809127L (en) ALONE MINER
FI890886A0 (en) CRYSTALLINE N- (S-3-METHYLHEPTANOYL) -D-GAMMA-GLUTAMYL-GLYCYL-D-ALANIN OCH FOERFARANDEN FOER DESS FRAMSTAELLNING SAMT MELLANPRODUKTER.
SU944282A1 (en) ETHYL ETHER HYDROCHLORIDE SUBSTITUTED WITH BROM-CONTAINING 3-HEXENIC ACID, CONNECTING HERBICIDAL ACTIVITY
SE8503089D0 (en) THERAPEUTICALLY ACTIVE, HUMAN STABILIZING AGENTS